By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocept, Inc. 

2151 Las Palmas Drive
Suite C
Carlsbad  California  92009  U.S.A.
Phone: 760-804-9580 Fax: 760-804-6238



Company News
Biocept (BIOC) Awarded U.S. Patent With Broad Claims For Antibody Capture Of Targets Of Interest On Any Solid Surface Including Ctcs And Other Materials Shed By Solid Tumors Into Blood 5/22/2017 6:51:21 AM
Biocept (BIOC) Reports First Quarter 2017 Financial Results 5/12/2017 8:33:35 AM
The Addario Lung Cancer Medical Institute And Biocept (BIOC) Announce Collaboration And Initiation Of Landmark ALCMI-009 Liquid Biopsy Clinical Trial In Lung Cancer 5/10/2017 7:37:02 AM
Biocept (BIOC) To Release First Quarter 2017 Financial Results And Host Investor Conference Call On May 11, 2017 5/3/2017 10:30:33 AM
Biocept (BIOC) Awarded Additional Patent In Japan Expanding Intellectual Property Estate To 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform 4/18/2017 7:01:30 AM
Biocept (BIOC) Announces Collaboration With The OHSU Knight Cancer Institute To Increase Clinical Adoption Of Liquid Biopsy Testing And To Co-Develop Additional Assay Platform Capabilities 4/3/2017 7:52:59 AM
SoCal's Biocept (BIOC) Rakes in $9.3 Million Financing 3/28/2017 7:28:50 AM
Biocept, Inc. (BIOC) And Catalyst Pharma (CPRX) Collaborate To Provide Liquid Biopsy Testing For Small Cell Lung Cancer To Patients With Lambert Eaton Myasthenic Syndrome (LEMS) 3/14/2017 6:43:10 AM
Biocept, Inc. (BIOC) Reports Fourth Quarter and Full Year 2016 Financial Results 3/8/2017 11:25:05 AM
Biocept, Inc. (BIOC) To Release 2016 Fourth Quarter And Full Year Financial Results And Host Investor Conference Call On March 7, 2017 2/21/2017 10:44:10 AM